Fate Therapeutics Falls To US$2.65, But Insiders Sold At Lower Price

Simply Wall StOct 26 21:11

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireOct 3 04:01

Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference

GlobeNewswireSep 13 04:01

Fate Therapeutics Strengthens Legal Safeguards for Leadership

TipRanksAug 31 04:49

HC Wainwright & Co. Reiterates Neutral on Fate Therapeutics, Maintains $5 Price Target

BenzingaAug 22 19:34 · Ratings

Broker Revenue Forecasts For Fate Therapeutics, Inc. (NASDAQ:FATE) Are Surging Higher

Yahoo FinanceAug 22 19:04